SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-11-016618
Filing Date
2011-03-23
Accepted
2011-03-23 16:40:54
Documents
4
Period of Report
2011-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v215716_8k.htm 8-K 32200
2 v215716_ex10-1.htm EX-10.1 346376
3 v215716_ex10-2.htm EX-10.2 91286
4 v215716_ex10-3.htm EX-10.3 91870
  Complete submission text file 0001144204-11-016618.txt   563045
Mailing Address 800 BELLEVUE WAY SUITE 400 BELLEVUE WA 98004
Business Address 800 BELLEVUE WAY SUITE 400 BELLEVUE WA 98004 425 646 2391
FIRST CHINA PHARMACEUTICAL GROUP, INC. (Filer) CIK: 0001432254 (see all company filings)

IRS No.: 743232809 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-54076 | Film No.: 11706883
SIC: 3663 Radio & Tv Broadcasting & Communications Equipment